A randomized, double-blind study has examined the risk of relapse in AD patients with psychosis or agitation/aggression when the atypical antipsychotic risperidone was withdrawn (Devanand et al. N Engl J Med 2012;367:1497-1507).
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with
